The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Neratinib after adjuvant chemotherapy and trastuzumab in HER2-positive early breast cancer: Primary analysis at 2 years of a phase 3, randomized, placebo-controlled trial (ExteNET).
 
Arlene Chan
Consulting or Advisory Role - Pfizer
Speakers' Bureau - Pierre Fabre
Travel, Accommodations, Expenses - Pierre Fabre
 
Suzette Delaloge
Honoraria - Novartis; Roche Pharma AG
Consulting or Advisory Role - Novartis; Pfizer; Roche Pharma AG
Research Funding - Novartis; Pfizer
Travel, Accommodations, Expenses - Amgen; Novartis; Roche Pharma AG
 
Frankie Ann Holmes
Consulting or Advisory Role - bioTheranostics; Sandoz
 
Beverly Moy
Consulting or Advisory Role - MOTUS (I); Olympus (I)
 
Hiroji Iwata
Honoraria - AstraZeneca; Bristol-Myers Squibb; Chugai Pharma; Daiichi Sankyo; Eisai; GlaxoSmithKline; Nippon Kayaku; Novartis; Pfizer; Sanofi; Taiho Pharmaceutical; Takeda
Consulting or Advisory Role - Daiichi Sankyo; Novartis
Research Funding - Bayer; Chugai Pharma; Daiichi Sankyo; GlaxoSmithKline; Nippon Kayaku; Novartis; Parexel; Pfizer
 
Vernon J. Harvey
No Relationships to Disclose
 
Nicholas J. Robert
Consulting or Advisory Role - New Century Health
 
Tajana Silovski
No Relationships to Disclose
 
Erhan Gokmen
Honoraria - GlaxoSmithKline; Pfizer; Roche Pharma AG
Consulting or Advisory Role - Bristol-Myers Squibb; Pfizer
Research Funding - Bristol-Myers Squibb; GlaxoSmithKline; Novartis; Roche Pharma AG
Travel, Accommodations, Expenses - Pfizer; Roche Pharma AG
 
Gunter Von Minckwitz
Employment - GBG Forschungs
Leadership - GBG Forschungs
Stock and Other Ownership Interests - GBG Forschungs
Research Funding - Amgen (Inst); AstraZeneca (Inst); Boehringer Ingelheim (Inst); Celgene (Inst); GlaxoSmithKline (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst); Sanofi (Inst); Teva (Inst)
 
Bent Ejlertsen
Research Funding - Amgen; Novartis; Puma Biotechnology; Roche Pharma AG
Travel, Accommodations, Expenses - Roche Pharma AG
 
Stephen K. L. Chia
Honoraria - Genomic Health; Novartis; Roche
Consulting or Advisory Role - Novartis; Roche
Speakers' Bureau - Genomic Health
Research Funding - Novartis (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Celgene; Roche
 
Janine Mansi
No Relationships to Disclose
 
Carlos H. Barrios
Honoraria - Boehringer Ingelheim; Eisai; GlaxoSmithKline; Novartis; Pfizer; Roche/Genentech; Sanofi
Consulting or Advisory Role - Astellas Pharma; Boehringer Ingelheim; Eisai; GlaxoSmithKline; Novartis; Pfizer; Roche/Genentech
Research Funding - Amgen; AstraZeneca; Boehringer Ingelheim; Celgene; Eisai; GlaxoSmithKline; Lilly; Novartis; Pfizer; Roche/Genentech; Sanofi
 
Michael Gnant
Employment - Sandoz (I)
Honoraria - Amgen; AstraZeneca; GlaxoSmithKline; NanoString Technologies; Novartis; Roche Pharma AG
Consulting or Advisory Role - Accelsiors; AstraZeneca; Novartis
Research Funding - GlaxoSmithKline; Novartis; Pfizer; Roche Pharma AG; Sanofi; Smiths Medical
 
Alvin Wong
Employment - Puma Biotechnology
Leadership - Puma Biotechnology
Stock and Other Ownership Interests - Gilead Sciences; Proteolix; Puma Biotechnology
Travel, Accommodations, Expenses - Puma Biotechnology
 
Richard Bryce
Employment - Puma Biotechnology
Leadership - Puma Biotechnology
Stock and Other Ownership Interests - Puma Biotechnology
 
Bin Yao
Employment - Puma Biotechnology
Stock and Other Ownership Interests - Amgen; Puma Biotechnology
 
Miguel Martin
Honoraria - Amgen; Novartis
Consulting or Advisory Role - Celgene; Novartis; Pfizer; Roche Pharma AG
Research Funding - Novartis